✦ LIBER ✦

Follow-up of recurrent hepatitis D and delta in liver allograft recipients treated with interferon alpha (IFNa)

✍ Scribed by König, V.; Hopf, U.; Bechstein, W.O.; Blumhardt, G.; Steffen, R.; Neuhaus, R.; Lobeck, H.; Neuhaus, P.

Book ID: 123555527
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 122 KB
Volume: 11
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(90)91476-D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Follow-up of recurrent hepatitis B and d

Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-α

✍ Hopf, U.; Neuhaus, P.; Lobeck, H.; König, V.; Küther, S.; Bauditz, J.; Bechstein 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 397 KB

Effects of interferon treatment on liver

Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation

✍ R. Todd Stravitz; Mitchell L. Shiffman; Arun J. Sanyal; Velimir A. Luketic; Rich 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 938 KB

Recurrent hepatitis C after liver transplantation remains a significant cause of graft loss and retransplantation. Although treatment of recurrent hepatitis C with interferon-based regimens has become widely accepted as safe and can lead to sustained virologic clearance of hepatitis C virus (HCV) RN

Treatment of chronic hepatitis B and C w

Treatment of chronic hepatitis B and C with interferon-alpha in renal allograft recipients: preliminary results

✍ M. Durlik; Z. Rancewicz; Z. Gaciong; D. Rowińska; M. Nowaczyk; G. Korczak-Kowals 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 266 KB

Clinical significance of breakthrough ph

Clinical significance of breakthrough phenomenon in liver transplant patients with recurrent hepatitis C treated with interferon-ALPHA AND ribaviria

✍ Aejaz Nasir; Gregory A. Smallwood; Andrei C. Stieber; Thomas G. Heffron; Michael 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Preliminary treatment results of pegylat

Preliminary treatment results of pegylated interferon alpha 2B and ribavirin in liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2B and ribavirin

✍ G.W. Neff; M. Montalbano; N. Ozden; H. Muslu; Y.M. Lee; K. Safdar; R. Morrero; J 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Treatment of naïve hepatitis C recurrenc

Treatment of naïve hepatitis C recurrence (HCV-R) in liver transplant recipients with pegylated interferon alpha-2B and ribavirin

✍ G.W. Neff; M. Montalbano; N. Ozden; H. Muslu; Y.M. Lee; G. Slapak; K. Safdar; R. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 321 KB